179 related articles for article (PubMed ID: 36074798)
61. Castleman Disease.
Wang W; Medeiros LJ
Surg Pathol Clin; 2019 Sep; 12(3):849-863. PubMed ID: 31352991
[TBL] [Abstract][Full Text] [Related]
62. Evolution of Pulmonary Involvement in Idiopathic Multicentric Castleman Disease-Not Otherwise Specified: From Nodules to Cysts or Consolidation.
Zhou J; Zhang L; Liu X; Zhang M; Li J; Zhang W
Chest; 2023 Aug; 164(2):418-428. PubMed ID: 36963752
[TBL] [Abstract][Full Text] [Related]
63. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F; Voorhees P; Dispenzieri A; Fosså A; Srkalovic G; Ide M; Munshi N; Schey S; Streetly M; Pierson SK; Partridge HL; Mukherjee S; Shilling D; Stone K; Greenway A; Ruth J; Lechowicz MJ; Chandrakasan S; Jayanthan R; Jaffe ES; Leitch H; Pemmaraju N; Chadburn A; Lim MS; Elenitoba-Johnson KS; Krymskaya V; Goodman A; Hoffmann C; Zinzani PL; Ferrero S; Terriou L; Sato Y; Simpson D; Wong R; Rossi JF; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Oksenhendler E; Fajgenbaum DC
Blood; 2018 Nov; 132(20):2115-2124. PubMed ID: 30181172
[TBL] [Abstract][Full Text] [Related]
64. [Analysis of the clinicopathologic features as well as diagnosis and treatment of 59 patients with Castleman disease].
Wang J; Liang LJ; Wang YM; Mei ZY; Liu YZ; Liu LN; Fang BJ; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):666-670. PubMed ID: 32942821
[No Abstract] [Full Text] [Related]
65. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
[TBL] [Abstract][Full Text] [Related]
66. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature.
Cheng JL; Cui J; Wang Y; Xu ZZ; Liu F; Liang SB; Tian H
World J Gastroenterol; 2018 Sep; 24(34):3958-3964. PubMed ID: 30228787
[TBL] [Abstract][Full Text] [Related]
67. Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
Nishimura Y; Nishikori A; Sawada H; Czech T; Otsuka Y; Nishimura MF; Mizuno H; Sawa N; Momose S; Ohsawa K; Otsuka F; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):99-105. PubMed ID: 35249898
[TBL] [Abstract][Full Text] [Related]
68. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
Lang E; Sande B; Brodkin S; van Rhee F
Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
[TBL] [Abstract][Full Text] [Related]
69. Indolent T-Lymphoblastic Proliferation in Idiopathic Multicentric Castleman Disease.
Karki NR; Arfa AS; Savage N; Kutlar A
Acta Haematol; 2022; 145(2):214-220. PubMed ID: 34818661
[TBL] [Abstract][Full Text] [Related]
70. Practical Management of Castleman's Disease.
Alzahrani MF; Radwi M; Leitch HA
Acta Haematol; 2016; 136(1):16-22. PubMed ID: 27160307
[TBL] [Abstract][Full Text] [Related]
71. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease.
Siegel MO; Ghafouri S; Ajmera R; Simon GL
Int J Infect Dis; 2016 Jul; 48():49-51. PubMed ID: 27173076
[TBL] [Abstract][Full Text] [Related]
72. [Castleman disease. Histopathological and immunohistochemical analysis of 39 cases].
Sevilla-Lizcano DB; Frias-Soria CL; Ortiz-Hidalgo C
Gac Med Mex; 2017; 153(5):550-558. PubMed ID: 29099112
[TBL] [Abstract][Full Text] [Related]
73. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
74. Rare Association Between Idiopathic Multicentric Castleman Disease, Nephrotic Syndrome and Polyneuropathy in an Immunocompetent Patient.
Landeiro L; Freitas AC; Proença M; Cabeçadas J; Nunes A; Bayão Horta A
Eur J Case Rep Intern Med; 2021; 8(10):002831. PubMed ID: 34790625
[TBL] [Abstract][Full Text] [Related]
75. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
[No Abstract] [Full Text] [Related]
76. Human immunodeficiency virus-associated multicentric Castleman disease refractory to antiretroviral therapy: clinical features, treatment and outcome.
Alzahrani M; Hull MC; Sherlock C; Griswold D; Leger CS; Leitch HA
Leuk Lymphoma; 2015 May; 56(5):1246-51. PubMed ID: 25093377
[TBL] [Abstract][Full Text] [Related]
77. Quantitative analysis of a rare disease network's international contact database and E-repository provides insights into biobanking in the electronic consent era.
Suarez A; Reilly C; Fajgenbaum DC
Orphanet J Rare Dis; 2019 Jul; 14(1):173. PubMed ID: 31296233
[TBL] [Abstract][Full Text] [Related]
78. Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection: A case report.
Guayboon T; Chinthammitr Y; Sukpanichnant S; Horthongkham N; Angkasekwinai N
Medicine (Baltimore); 2021 Dec; 100(49):e28077. PubMed ID: 34889256
[TBL] [Abstract][Full Text] [Related]
79. When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China.
Liu Y; Yin X; Xu D; Lv Y; Zhu L; Yang M; Yao Q; Jin J; Huang L; Meng H; You L
Ther Adv Hematol; 2024; 15():20406207241229584. PubMed ID: 38357251
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]